FDAFDA · Food and drugs·Recall number D-0840-2026
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Published September 9, 2026 · Recall initiated: August 19, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- BUPRENORPHINE
- Manufacturer
- American Health Packaging
- Distributor
- US Nationwide.
- Lot
- Lot # 1030023, Exp Date: 06/30/2027.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.
Recalert also tracks expiration dates so you can sell stock before it becomes a loss.